Bluejay Diagnostics | 8-K: Current report
Bluejay Diagnostics | 8-K: Current report
Bluejay Diagnostics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Anson Funds Management LP(5.1%),Anson Management GP LLC(5.1%), etc.
Bluejay Diagnostics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(4.99%),Steven Boyd(4.99%)
Bluejay Diagnostics | 10-Q: Q3 2024 Earnings Report
Bluejay Diagnostics | 8-K: Current report
Bluejay Diagnostics | 8-K: Current report
Bluejay Diagnostics | DEFA14A: Others
Bluejay Diagnostics | DEF 14A: Definitive information statements
Bluejay Diagnostics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Bluejay Diagnostics | 8-K: Current report
Bluejay Diagnostics | 8-K: Current report
Bluejay Diagnostics | 10-Q: Q2 2024 Earnings Report
Bluejay Diagnostics | DEF 14A: Definitive information statements
Bluejay Diagnostics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Bluejay Diagnostics | SC 13G: Statement of acquisition of beneficial ownership by individuals-L1 Capital Global Opportunities Master Fund, Ltd.(9.99%)
Bluejay Diagnostics | 8-K: Current report
Bluejay Diagnostics | 424B1: Prospectus
Bluejay Diagnostics | EFFECT: Others
Bluejay Diagnostics | CORRESP: CORRESP